RenBio

New York, United States

RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases.

$2.9M raised

Jul 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has RenBio raised?

RenBio has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in July 2024.

Who are RenBio's investors?

RenBio's investors include Wellcome Trust, DARPA, Ruentex Group.

Where is RenBio headquartered?

RenBio is headquartered in New York, United States.

What does RenBio do?

RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases.

What stage is RenBio at?

RenBio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 25, 2024.

MLA

"RenBio — Funding & Investors." VCBacked, July 25, 2024, https://www.vcbacked.co/company/renbio. Accessed July 2, 2026.

APA

VCBacked. (2024). RenBio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/renbio

Wikipedia (cite web)

{{cite web |title=RenBio — Funding & Investors |url=https://www.vcbacked.co/company/renbio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 25, 2024.